TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can't tolerate its side effects and quit ...

Lee’s team at the Huntsman Cancer Institute reviewed 14 studies, featuring a total of 9,500 patients with head and neck cancer and nearly 15,800 people without cancer, comparing their ...

British rockstar David Roach, frontman of Junkyard, has been hospitalized after he was diagnosed with an aggressive squamous ...

Head and neck cancer, referring to cancers of the oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary glands, is the seventh-most common type of cancer.There are over ...

In the United States, head and neck cancers make up 4% of all cancers, with more than 71,000 new cases and more than 16,000 deaths expected in 2024, according to the National Foundation for Cancer ...

A large, multicenter study published in JAMA Otolaryngology -- Head & Neck Surgery revealed that adults with cannabis dependence, known as cannabis use disorder, are 3.5 to 5 times more likely to ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with resectable locally advanced head and neck squamous ...

Source Reference: Bryan ME, et al "Direct comparison of alternative blood-based approaches for early detection and diagnosis of HPV-associated head and neck cancers" Clin Cancer Res 2025; DOI: 10. ...

VIENNA, Va., March 17, 2025--Head and Neck Cancer Registration Study Protocol clears FDA review—in talks with potential partners Interested in commercialization of Multikine.

CHARLESTON, S.C. (WCSC) - Trident Medical Center is celebrating two-time Super Bowl winner and South Carolina native Jim Stuckey for being cancer-free. His story is raising awareness for this National ...

From cough to non-healing ulcer in mouth, know the early warning signs of head and neck cancer. Tuesday, Jun 24, 2025. New Delhi o C. Subscribe. Sign in. My Account. Subscribe. Enjoy unlimited access.

In part 2 of this interview, Ravindra Uppaluri, MD, PhD, director of head and neck surgical oncology at Dana-Farber Brigham Cancer Center, lead investigator of the phase 3 KEYNOTE-689 trial ...